• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于皂苷的佐剂摄取以及CD11b+树突状细胞和巨噬细胞对抗原交叉呈递的诱导作用。

Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages.

作者信息

Huis In 't Veld Lisa Gm, Cornelissen Lenneke Am, van den Bogaard Lune, Ansems Marleen, Ho Nataschja I, Adema Gosse J

机构信息

Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

NPJ Vaccines. 2025 Jan 22;10(1):15. doi: 10.1038/s41541-024-01056-y.

DOI:10.1038/s41541-024-01056-y
PMID:39843492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11754886/
Abstract

Saponin-based adjuvants (SBAs) distinguish themselves as vaccine adjuvants by instigating a potent activation of CD8+ T cells. Previously, we discovered SBA's ability to induce cross-presentation in dendritic cells (DCs) leading to CD8+ T cell activation. Moreover, the MHCIICD11b bone marrow-derived DC (BMDC) subset was identified to be the most responsive DC subset to SBA treatment. To further investigate SBA's mode of action, labeling of SBAs was optimized with the fluorescent dye SP-DiIC(3). Efficient uptake of SBAs occurs specifically by MHCIICD11b BMDCs and bone marrow-derived macrophages (BMDMs) in vitro and cDC2s and macrophages ex vivo. Furthermore, SBAs are primarily taken up by clathrin-mediated endocytosis and uptake induces lipid bodies and antigen translocation to the cytosol in MHCIICD11b BMDCs and BMDMs. Importantly, BMDMs treated with SBAs exhibit cross-presentation leading to potent CD8+ T cells activation. Our findings explain the potency of SBAs as vaccine adjuvants and contribute to vaccine development.

摘要

基于皂苷的佐剂(SBA)通过强烈激活CD8+ T细胞,使其在疫苗佐剂中脱颖而出。此前,我们发现SBA能够在树突状细胞(DC)中诱导交叉呈递,从而导致CD8+ T细胞活化。此外,MHCII+CD11b骨髓来源的DC(BMDC)亚群被确定为对SBA处理反应最灵敏的DC亚群。为了进一步研究SBA的作用模式,我们用荧光染料SP-DiIC(3)对SBA进行了优化标记。在体外,MHCII+CD11b BMDC和骨髓来源的巨噬细胞(BMDM)能够特异性地高效摄取SBA,在体内,cDC2和巨噬细胞也能摄取。此外,SBA主要通过网格蛋白介导的内吞作用被摄取,摄取会诱导MHCII+CD11b BMDC和BMDM中脂滴的形成以及抗原向细胞质的转运。重要的是,用SBA处理的BMDM表现出交叉呈递,从而导致强大的CD8+ T细胞活化。我们的研究结果解释了SBA作为疫苗佐剂的效力,并为疫苗开发做出了贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/3005aeb45a06/41541_2024_1056_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/a9325f113c48/41541_2024_1056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/6aeb6ef651c8/41541_2024_1056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/e8514301b89d/41541_2024_1056_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/68ba961a0a81/41541_2024_1056_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/3005aeb45a06/41541_2024_1056_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/a9325f113c48/41541_2024_1056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/6aeb6ef651c8/41541_2024_1056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/e8514301b89d/41541_2024_1056_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/68ba961a0a81/41541_2024_1056_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/11754886/3005aeb45a06/41541_2024_1056_Fig5_HTML.jpg

相似文献

1
Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages.基于皂苷的佐剂摄取以及CD11b+树突状细胞和巨噬细胞对抗原交叉呈递的诱导作用。
NPJ Vaccines. 2025 Jan 22;10(1):15. doi: 10.1038/s41541-024-01056-y.
2
Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation.基于皂苷的佐剂诱导树突状细胞交叉呈递依赖于 PERK 激活。
Cell Mol Life Sci. 2022 Apr 9;79(5):231. doi: 10.1007/s00018-022-04253-x.
3
Saponin-based adjuvants enhance antigen cross-presentation in human CD11c CD1c CD5 CD163 conventional type 2 dendritic cells.基于皂素的佐剂增强了人类 CD11c+CD1c+CD5+CD163+常规 2 型树突状细胞的抗原交叉呈递。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-007082.
4
Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.基于皂苷的佐剂通过细胞内脂滴形成诱导树突状细胞交叉呈递。
Nat Commun. 2016 Nov 7;7:13324. doi: 10.1038/ncomms13324.
5
Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8 T cells.经工程改造表达膜结合抗原的外膜囊泡可对树突状细胞进行交叉呈递,以激活 CD8 T 细胞。
Acta Biomater. 2019 Jun;91:248-257. doi: 10.1016/j.actbio.2019.04.033. Epub 2019 Apr 17.
6
Identification of dendritic cell precursor from the CD11c cells expressing high levels of MHC class II molecules in the culture of bone marrow with FLT3 ligand.在含有 FLT3 配体的骨髓培养物中,从 MHC Ⅱ类分子高表达的 CD11c 细胞中鉴定树突状细胞前体细胞。
Front Immunol. 2023 Nov 29;14:1179981. doi: 10.3389/fimmu.2023.1179981. eCollection 2023.
7
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?佐剂增强树突状细胞的交叉呈递:更有效的疫苗的关键?
Front Immunol. 2018 Dec 13;9:2874. doi: 10.3389/fimmu.2018.02874. eCollection 2018.
8
A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.小肠中 CD103+CD8alpha+树突状细胞的一个新亚群表达 TLR3、TLR7 和 TLR9,并诱导 Th1 反应和 CTL 活性。
J Immunol. 2011 Jun 1;186(11):6287-95. doi: 10.4049/jimmunol.1004036. Epub 2011 Apr 27.
9
Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes.肿瘤消融术联合 CpG 和皂角苷佐剂可影响肿瘤引流淋巴结中 IL-1 的产生和多功能 T 细胞数量。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000649.
10
In Vitro Bone Marrow-Derived Dendritic Cells (BMDC) Generation for Antigen Presentation Assay.用于抗原呈递分析的体外骨髓来源树突状细胞(BMDC)生成
Bio Protoc. 2025 Apr 20;15(8):e5278. doi: 10.21769/BioProtoc.5278.

引用本文的文献

1
The Elicitation of an Antigen-Specific Antibody Immune Response Using a Nanoparticulate Adjuvant Derived from .使用源自……的纳米颗粒佐剂引发抗原特异性抗体免疫反应
Molecules. 2025 Aug 9;30(16):3328. doi: 10.3390/molecules30163328.
2
Leaf Saponins of as Powerful Vaccine Adjuvants.作为强效疫苗佐剂的[植物名称]叶皂苷
Pharmaceutics. 2025 Jul 25;17(8):966. doi: 10.3390/pharmaceutics17080966.
3
Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization.

本文引用的文献

1
Long-lasting mRNA-encoded interleukin-2 restores CD8 T cell neoantigen immunity in MHC class I-deficient cancers.长效 mRNA 编码的白细胞介素 2 恢复 MHC Ⅰ类缺陷型癌症中 CD8 T 细胞新抗原免疫。
Cancer Cell. 2024 Apr 8;42(4):568-582.e11. doi: 10.1016/j.ccell.2024.02.013. Epub 2024 Mar 14.
2
Intratumoral administration of the immunologic adjuvant AS01 in combination with autologous CD1c (BDCA-1)/CD141 (BDCA-3) myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.在难治性晚期黑色素瘤患者中,瘤内给予免疫佐剂 AS01 联合自体 CD1c(BDCA-1)/CD141(BDCA-3)髓样树突状细胞加伊匹单抗和静脉注射纳武利尤单抗。
J Immunother Cancer. 2024 Jan 11;12(1):e008148. doi: 10.1136/jitc-2023-008148.
3
基质-M佐剂可触发炎性小体激活,并通过诱导溶酶体膜通透性实现抗原交叉呈递。
NPJ Vaccines. 2025 Aug 5;10(1):184. doi: 10.1038/s41541-025-01243-5.
4
Eliciting antitumor immunity via therapeutic cancer vaccines.通过治疗性癌症疫苗激发抗肿瘤免疫力。
Cell Mol Immunol. 2025 Jul 9. doi: 10.1038/s41423-025-01316-4.
5
Harnessing Thalassochemicals: Marine Saponins as Bioactive Agents in Nutraceuticals and Food Technologies.利用海洋化学成分:海洋皂苷作为营养保健品和食品技术中的生物活性剂
Mar Drugs. 2025 May 26;23(6):227. doi: 10.3390/md23060227.
Saponin-based adjuvants enhance antigen cross-presentation in human CD11c CD1c CD5 CD163 conventional type 2 dendritic cells.基于皂素的佐剂增强了人类 CD11c+CD1c+CD5+CD163+常规 2 型树突状细胞的抗原交叉呈递。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-007082.
4
Guidelines for mouse and human DC generation.小鼠和人树突状细胞生成的指南。
Eur J Immunol. 2023 Nov;53(11):e2249816. doi: 10.1002/eji.202249816. Epub 2022 Oct 27.
5
NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses.接种 NVX-CoV2373 可诱导产生针对 SARS-CoV-2 的功能性 CD4+ 和 CD8+ T 细胞应答。
J Clin Invest. 2022 Oct 3;132(19):e160898. doi: 10.1172/JCI160898.
6
CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity.CD206+ 肿瘤相关巨噬细胞交叉呈递肿瘤抗原并驱动抗肿瘤免疫。
JCI Insight. 2022 Jun 8;7(11):e155022. doi: 10.1172/jci.insight.155022.
7
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.在缓解期老年 AML 患者中进行 WT1 重组蛋白疫苗接种的首次人体研究:单中心经验。
Cancer Immunol Immunother. 2022 Dec;71(12):2913-2928. doi: 10.1007/s00262-022-03202-8. Epub 2022 Apr 27.
8
Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation.基于皂苷的佐剂诱导树突状细胞交叉呈递依赖于 PERK 激活。
Cell Mol Life Sci. 2022 Apr 9;79(5):231. doi: 10.1007/s00018-022-04253-x.
9
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.新型冠状病毒疫苗 NVX-CoV2373 的安全性和有效性。
N Engl J Med. 2021 Sep 23;385(13):1172-1183. doi: 10.1056/NEJMoa2107659. Epub 2021 Jun 30.
10
CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01.CCR2 和 Flt3 依赖性炎症性常规 2 型树突状细胞对于人用疫苗佐剂系统 AS01 诱导适应性免疫是必需的。
Front Immunol. 2021 Jan 14;11:606805. doi: 10.3389/fimmu.2020.606805. eCollection 2020.